Quantum BioPharma Ltd. Key Management Personnel Compensation
Quantum BioPharma Ltd. (QNTM) reported Key Management Personnel Compensation of $3.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2026-03-26
CAD
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2019-12-31 | 17.31M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 5.03M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Key Management Personnel Compensation 3 month | Key Management Personnel Compensation 6 month | Key Management Personnel Compensation 9 month | Key Management Personnel Compensation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $31.84K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $1.75M derived: sum of 2 quarters · filed 2026-03-26 | $1.97M derived: sum of 3 quarters · filed 2026-03-26 | $3.50M 20-F · filed 2026-03-26 |
| 2025-09-30 | $1.72M 6-K · filed 2025-11-06 | $1.94M derived: sum of 2 quarters · filed 2025-11-06 | $3.46M 6-K · filed 2025-11-06 | $1.40M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $216.64K 6-K · filed 2025-08-07 | $1.74M 6-K · filed 2025-08-07 | -$324.96K derived: sum of 3 quarters · filed 2026-03-26 | $913.83K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $1.52M 6-K/A · filed 2025-06-16 | -$541.61K derived: sum of 2 quarters · filed 2026-03-26 | $697.19K derived: sum of 3 quarters · filed 2026-03-26 | $849.48K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | -$2.07M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$827.42K derived: sum of 2 quarters · filed 2026-03-26 | -$675.14K derived: sum of 3 quarters · filed 2026-03-26 | $1.99M 20-F · filed 2026-03-26 |
| 2024-09-30 | $1.24M 6-K · filed 2025-11-06 | $1.39M derived: sum of 2 quarters · filed 2025-11-06 | $4.06M 6-K · filed 2025-11-06 | $2.08M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $152.29K 6-K · filed 2025-08-07 | $476.53K 6-K · filed 2025-08-07 | $841.26K derived: sum of 3 quarters · filed 2026-03-26 | $1.22M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $324.24K 6-K/A · filed 2025-06-16 | $688.98K derived: sum of 2 quarters · filed 2026-03-26 | $1.06M derived: sum of 3 quarters · filed 2026-03-26 | $1.71M derived: sum of 4 quarters · filed 2026-03-26 |
| 2023-12-31 | $364.73K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $739.40K derived: sum of 2 quarters · filed 2026-03-26 | $1.38M derived: sum of 3 quarters · filed 2026-03-26 | $3.38M 20-F · filed 2026-03-26 |
| 2023-09-30 | $374.67K 6-K · filed 2024-11-12 | $1.02M derived: sum of 2 quarters · filed 2024-11-12 | $3.01M 6-K · filed 2024-11-12 | |
| 2023-06-30 | $641.45K 6-K/A · filed 2024-08-19 | $3.02M 6-K/A · filed 2024-08-19 | ||
| 2022-12-31 | $3.19M 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | $8.96M 20-F · filed 2024-04-02 | |||
| 2020-12-31 | $9.98M 20-F · filed 2023-03-31 | |||
| 2019-12-31 | $13.02M 20-F · filed 2022-03-31 |